WEP Clinical

WEP Clinical is a specialized, full-service CRO with a distinct dual focus on traditional clinical trial execution and niche patient access programs. The company leverages over 16 years of collective experience in Expanded Access Programs (EAPs) to provide sponsors with pathways to deliver investigational therapies to patients outside of trials, while also managing over 60 clinical programs worldwide. Its business model is built on providing tailored, embedded support to biotech sponsors, aiming to expedite therapies to market. WEP operates as a private, revenue-generating services company, capitalizing on the growing demand for real-world evidence and patient-centric drug development strategies.

Integrated service methodology specializing in clinical trial management and Expanded Access/Post-Trial Access Program design and execution, with a focus on strategic real-world data collection.

WEP Clinical competes in the fragmented CRO market, facing giants like IQVIA, ICON, and Parexel, as well as numerous niche players. Its primary differentiation is deep, specialized expertise in Expanded Access Programs and a flexible, embedded service model tailored for biotech sponsors, a segment larger CROs may serve with less customization.